Vickerman Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Sell
473
-5
-1% -$5.11K 0.11% 71
2026
Q1
$440K Sell
478
-39
-8% -$39.5K 0.09% 72
2025
Q4
$556K Buy
517
+141
+38% +$135K 0.11% 70
2025
Q3
$287K Sell
376
-114
-23% -$84.8K 0.06% 73
2025
Q2
$382K Sell
490
-89
-15% -$69.2K 0.08% 67
2025
Q1
$478K Sell
579
-149
-20% -$124K 0.11% 66
2024
Q4
$562K Buy
728
+277
+61% +$229K 0.15% 55
2024
Q3
$400K Buy
+451
New +$405K 0.12% 57

Other funds holding LLY

Vickerman Investment Advisors's LLY Position: Q2 2026 in Review

Vickerman Investment Advisors reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $5.11K and leaving 473 shares worth $567K. The position accounts for 0.11% of the portfolio, ranked #71.

Vickerman Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vickerman Investment Advisors held 473 shares of Eli Lilly worth $567K as of Q2 2026.
  • Vickerman Investment Advisors sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.11% of Vickerman Investment Advisors's portfolio in Q2 2026, its #71 holding.
  • Vickerman Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vickerman Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.